Takeda Pharmaceutical Company Limited - Company & Market Research Reports

Home /
Companies /
Takeda Pharmaceutical Company Limited

Takeda Pharmaceuticals is the largest pharmaceutical company in Asia and a top 15 pharmaceutical company in the world. It provides products in various therapeutic areas, including gastroenterology, oncology, central nervous system, cardiovascular and metabolic, vaccines, and others. Takeda was founded in 1781 and operates two primary bases in Japan in Osaka and Tokyo. Its global operations are based in Zurich, Switzerland.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 197
Endocrine and Metabolic Disorders Drugs 172
Gastrointestinal Drugs 148
Central Nervous System Drugs 140
Immune Disorders Drugs 137
Biopharmaceuticals 92
Drug Discovery 87
Hematological Drugs 82
Vaccines 81
Pharmaceuticals 80
Clinical Trials 79
Infectious Diseases Drugs 67
Cardiovascular Drugs 59
Diabetes Drugs 57
Leukemia Drugs 57
Mental Disorders Drugs 46
Musculoskeletal Disorders Drugs 44
Lymphoma Drugs 42
Infusions and Injectables 35
Over the Counter (OTC) Drugs 33
Liver and Kidney Disorders Drugs 33
Lung Cancer Drugs 22
Pharmaceutical Manufacturing 22
Respiratory Drugs 21
Sexual and Reproductive Health Drugs 21
Drug Delivery 20
Antibiotics 16
Drugs by Therapeutic Area 15
Analgesics 15
Prostate Cancer Drugs 14
Pharmaceutical Intermediates 13
Skin Cancer Drugs 12
Schizophrenia Drugs 12
Immunosuppressive Drugs 12
Optical Disorders Drugs 10
Anti-Obesity Drugs 10
Alzheimer's Disease Drugs 10
Generic Drugs 7
Biosimilars and Biosuperiors 7
Psoriasis Drugs 7
Addiction Disorders Drugs 6
Animal Pharmaceuticals 6
Colon Cancer Drugs 6
Thyroid Cancer Drugs 6
Uterine Cancer Drugs 6
Dermatological Drugs 6
Urological Disorders Drugs 6
Brain Cancer Drugs 5
Transdermal and Transmucosal Drug Delivery 5
Liver Cancer Drugs 4
Breast Cancer Drugs 4
Cervical Cancer Drugs 4
Company Reports 3
Kidney Cancer Drugs 3
HIV/AIDS Drugs 3
Ovarian Cancer Drugs 2
Cough and Cold Drugs 2
Anesthetic Drugs 2
Cancer Vaccines 2
Pancreatic Cancer Drugs 2
Vitamins and Dietary Supplements 2
Pharmacoeconomics 1
Bladder Cancer Drugs 1
Inhalers and Nebulisers 1
Anxiety Drugs 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



279 reviews

1,722 Results (Page 20 of 87)
- Relevance
  Sort by

Europe Non Hodgkin Lymphoma Therapeutics Market Size, Share & Trends Analysis Report By Cell Type (B-Cell Lymphoma and T-Cell Lymphoma), By Therapy Type (Radiation Therapy, Chemotherapy, Targeted Therapy, and Others), By Country and Growth Forecast, 2023 - 2030

 Report
January 2024
108 Pages
Europe

From

€1320EUR$1,500USD£1,145GBP

Asia Pacific Non Hodgkin Lymphoma Therapeutics Market Size, Share & Trends Analysis Report By Cell Type (B-Cell Lymphoma and T-Cell Lymphoma), By Therapy Type (Radiation Therapy, Chemotherapy, Targeted Therapy, and Others), By Country and Growth Forecast, 2023 - 2030

 Report
January 2024
109 Pages
Asia Pacific

From

€1320EUR$1,500USD£1,145GBP

Obstructive Sleep Apnea (OSA) - Pipeline Insight, 2025

 Clinical Trials
April 2025
80 Pages
Global

From

€1759EUR$2,000USD£1,527GBP

Cinepazide Maleate API Market - Global Forecast to 2030

 Report
August 2025
181 Pages
Global

From

€3119EUR$3,545USD£2,706GBP

€3465EUR$3,939USD£3,007GBP

Head And Neck Cancer Therapeutics Market Size, Share & Trends Analysis Report By Therapy Type (Chemotherapy, Immunotherapy, Targeted Therapy), By Route of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2033

 Report
July 2025
105 Pages
Global

From

€5234EUR$5,950USD£4,542GBP

NEED HELP FINDING THE RIGHT PRODUCT? Hoseok will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Aids Related Cancer Global Market Insights 2022, Analysis and Forecast to 2027, by Manufacturers, Regions, Technology, Application, Product Type

 Report
March 2022
80 Pages
Global

From

€3500EUR$4,262USD£3,143GBP

Gynecological Cancer Drugs - Global Strategic Business Report

 Report
September 2025
193 Pages
Global

From

€5146EUR$5,850USD£4,465GBP

Myeloproliferative Neoplasms Treatment - Global Strategic Business Report

 Report
September 2025
368 Pages
Global

From

€5146EUR$5,850USD£4,465GBP

Adenoid Cystic Carcinoma - Global Strategic Business Report

 Report
September 2025
386 Pages
Global

From

€5146EUR$5,850USD£4,465GBP

Angiosarcoma Treatment - Global Strategic Business Report

 Report
September 2025
390 Pages
Global

From

€5146EUR$5,850USD£4,465GBP

Myeloproliferative Disorders Drugs - Global Strategic Business Report

 Report
September 2025
172 Pages
Global

From

€5146EUR$5,850USD£4,465GBP

Epithelioma Treatment - Global Strategic Business Report

 Report
September 2025
380 Pages
Global

From

€5146EUR$5,850USD£4,465GBP

Metastatic Cancer Drugs - Global Strategic Business Report

 Report
September 2025
377 Pages
Global

From

€5146EUR$5,850USD£4,465GBP

Bortezomib - Global Strategic Business Report

 Report
September 2025
377 Pages
Global

From

€5146EUR$5,850USD£4,465GBP

Desmoid Tumors - Global Strategic Business Report

 Report
September 2025
286 Pages
Global

From

€5146EUR$5,850USD£4,465GBP

Blastic Plasmacytoid Dendritic Cell Neoplasm - Global Strategic Business Report

 Report
September 2025
285 Pages
Global

From

€5146EUR$5,850USD£4,465GBP

Cancer Biological Therapy - Global Strategic Business Report

 Report
September 2025
211 Pages
Global

From

€5146EUR$5,850USD£4,465GBP

Methylmalonic Acidemia Treatment Market - Global Forecast 2025-2030

 Report
August 2025
197 Pages
Global

From

€3119EUR$3,545USD£2,706GBP

€3465EUR$3,939USD£3,007GBP

Enzyme Replacement Therapy Drugs for Gaucher Disease Market - Global Forecast 2025-2030

 Report
August 2025
192 Pages
Global

From

€3119EUR$3,545USD£2,706GBP

€3465EUR$3,939USD£3,007GBP

Lansoprazole Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

 Report
May 2023
74 Pages
Global

From

€3500EUR$4,262USD£3,143GBP

1,722 Results (Page 20 of 87)
- 1
- 18
- 19
- 20
- 21
- 22

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.